Literature DB >> 1919432

Microdialysis--principles and applications for studies in animals and man.

U Ungerstedt1.   

Abstract

Microdialysis is a technique for sampling the chemistry of the individual tissues and organs of the body, and is applicable to both animal and human studies. The basic principle is to mimic the function of a capillary blood vessel by perfusing a thin dialysis tube implanted into the tissue with a physiological liquid. The perfusate is analysed chemically and reflects the composition of the extracellular fluid with time due to the diffusion of substances back and forth over the membrane. Microdialysis is thus a technique whereby substances may be both recovered from and supplied to a tissue. The most important features of microdialysis are as follows: it samples the extracellular fluid, which is the origin of all blood chemistry; it samples continuously for hours or days without withdrawing blood; and it purifies the sample and simplifies chemical analysis by excluding large molecules from the perfusate. However, the latter feature renders the technique unsuitable for sampling large molecules such as proteins. The technique has been extensively used in the neurosciences to monitor neurotransmitter release, and is now finding application in monitoring of the chemistry of peripheral tissues in both animal and human studies.

Entities:  

Mesh:

Year:  1991        PMID: 1919432     DOI: 10.1111/j.1365-2796.1991.tb00459.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  119 in total

1.  Microdialysis technique as a method to study the percutaneous penetration of methyl nicotinate through excised human skin, reconstructed epidermis, and human skin in vivo.

Authors:  E Boelsma; C Anderson; A M Karlsson; M Ponec
Journal:  Pharm Res       Date:  2000-02       Impact factor: 4.200

Review 2.  Science, medicine, and the future: Microdialysis.

Authors:  Markus Müller
Journal:  BMJ       Date:  2002-03-09

3.  Analyte flux at a biomaterial-tissue interface over time: implications for sensors for type 1 and 2 diabetes mellitus.

Authors:  Neda Rajamand Ekberg; Kerstin Brismar; Jonas Malmstedt; Mari-Anne Hedblad; Ulf Adamson; Urban Ungerstedt; Natalie Wisniewski
Journal:  J Diabetes Sci Technol       Date:  2010-09-01

4.  Metabolic changes detected by microdialysis during endotoxin shock and after endotoxin preconditioning.

Authors:  S Klaus; M Heringlake; K Block; J Nolde; K Staubach; L Bahlmann
Journal:  Intensive Care Med       Date:  2003-02-08       Impact factor: 17.440

Review 5.  Issues in pharmacokinetics and pharmacodynamics of anti-infective agents: distribution in tissue.

Authors:  Markus Müller; Amparo dela Peña; Hartmut Derendorf
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

6.  Microdialysis measurement of the absolute glucose concentration in subcutaneous adipose tissue allowing glucose monitoring in diabetic patients.

Authors:  J Bolinder; U Ungerstedt; P Arner
Journal:  Diabetologia       Date:  1992-12       Impact factor: 10.122

7.  Evidence for a predominant intrinsic sympathetic control of cerebral blood flow alterations in an animal model of cerebral arteriovenous malformation.

Authors:  Carsten Stüer; Toshiki Ikeda; Michael Stoffel; Gerd Luippold; Carlo Schaller; Bernhard Meyer
Journal:  Transl Stroke Res       Date:  2010-04-13       Impact factor: 6.829

8.  Muscle microdialysis to confirm sublethal ischemia in the induction of remote ischemic preconditioning.

Authors:  Arzu Bilgin-Freiert; Joshua R Dusick; Nathan R Stein; Maria Etchepare; Paul Vespa; Nestor R Gonzalez
Journal:  Transl Stroke Res       Date:  2012-04-10       Impact factor: 6.829

Review 9.  Changes in cerebral oxidative metabolism in patients with acute liver failure.

Authors:  P N Bjerring; F S Larsen
Journal:  Metab Brain Dis       Date:  2012-10-26       Impact factor: 3.584

10.  Evaluation of methotrexate tissue exposure by in situ microdialysis in a rat model.

Authors:  O Ekstrøm; A Andersen; D J Warren; K E Giercksky; L Slørdal
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.